These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6740540)

  • 1. Pulmonary infection with mycobacterium xenopi: review of treatment and response.
    Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1984 May; 39(5):376-82. PubMed ID: 6740540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis due to Mycobacterium kansasii.
    Elder JL; Edwards FG; Abrahams EW
    Aust N Z J Med; 1977 Feb; 7(1):8-13. PubMed ID: 266899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of pulmonary infection with mycobacterium xenopi].
    Kawamura M; Kusanagi Y; Satou Y; Itou S; Honma M; Shimoide H
    Nihon Kokyuki Gakkai Zasshi; 1998 Jan; 36(1):86-9. PubMed ID: 9611983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
    Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1983 Apr; 38(4):271-4. PubMed ID: 6867979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
    Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
    Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi.
    Costrini AM; Mahler DA; Gross WM; Hawkins JE; Yesner R; D'Esopo ND
    Am Rev Respir Dis; 1981 Jan; 123(1):104-9. PubMed ID: 7458072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review of pulmonary disease caused by Mycobacterium xenopi.
    Smith MJ; Citron KM
    Thorax; 1983 May; 38(5):373-7. PubMed ID: 6879487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
    Jenkins PA; Campbell IA;
    Respir Med; 2003 Apr; 97(4):439-44. PubMed ID: 12693807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary infection with nontuberculous mycobacteria.
    Contreras MA; Cheung OT; Sanders DE; Goldstein RS
    Am Rev Respir Dis; 1988 Jan; 137(1):149-52. PubMed ID: 3337456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary resection for Mycobacterium xenopi pulmonary infection.
    Lang-Lazdunski L; Offredo C; Le Pimpec-Barthes F; Danel C; Dujon A; Riquet M
    Ann Thorac Surg; 2001 Dec; 72(6):1877-82. PubMed ID: 11789763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.
    Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1981 May; 36(5):326-9. PubMed ID: 7313999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
    Gochi M; Kaneko Y; Seki A; Saitou Z; Samejima T; Seki Y; Takeda H; Kinoshita A; Kuwano K
    Kekkaku; 2012 Nov; 87(11):733-6. PubMed ID: 23367833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
    Sauret J; Hernández-Flix S; Castro E; Hernández L; Ausina V; Coll P
    Tuber Lung Dis; 1995 Apr; 76(2):104-8. PubMed ID: 7780090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary infection due to Mycobacterium xenopi.
    Terashima T; Sakamaki F; Hasegawa N; Kanazawa M; Kawashiro T
    Intern Med; 1994 Sep; 33(9):536-9. PubMed ID: 8000103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.